...the FDA authorized IVDs based on available data from contrived samples generated from a range of SARS-CoV-2 material sources (for example, gene specific RNA, synthetic RNA, or whole genome viral RNA) for analytical and clinical performance evaluation.
this is probably not going to be in the *ew york times, or on cnn.
the vIRIS we DONT have.
for y'all non readers:
...the FDA authorized IVDs based on available data from contrived samples generated from a range of SARS-CoV-2 material sources (for example, gene specific RNA, synthetic RNA, or whole genome viral RNA) for analytical and clinical performance evaluation.
this is probably not going to be in the *ew york times, or on cnn.